Skip to content
ICLR·Nasdaq·US

ICON

ICON is a global contract research organization that provides outsourced clinical development services to pharmaceutical, biotechnology, medical device, and government clients. Its services support clinical trials across the drug and device development lifecycle, including study design, management, data analysis, laboratory services, imaging, and commercialization support.

Thematic Position

Relationship Groups

Suppliers9
Customers3
Competitors3

Relationship details are part of the Pro plan.

Ended Relationships

5 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

regulatory constraint
U.S. FTC authority constrains ICON's handling of personal data and clinical trial information
SEC 20-FMay 27, 2026

The full regulatory passage is part of the Pro plan.

18 more · Regulatory and geopolitical insights are part of the Pro plan.